Evidence of physical ability to perform the requested privilege. Data from professional practice review by an organization(s) that currently privileges the applicant (if available). Peer and/or faculty recommendation. When renewing privileges, review of the practitionerâs performance within the hospital.
Janssen, however, also marketed Risperdal as a treatment for older people with agitation from dementia, which is not an FDA-approved use of the medication. In fact, it can be dangerous for older adults with dementia to take antipsychotics, including Risperdal, and Janssen had to pay a fine for misbranding the drug.
Drug abuse. Risperdal (the brand name for risperidone) is the most frequently prescribed antipsychotic medication in the U.S. The FDA has approved Risperdal for the treatment of schizophrenia, but it is not approved for children.